“…In preclinical rodent models of migraine, NTG-induced central sensitization is a well-characterized model that has demonstrated increased brain sodium levels [24], hypersensitivity to pain based on behavioral response [18,24,28,31,53], altered cerebral blood flow [22,27], increased cFos expression in the trigeminal nucleus caudalis (TNC) [24,54], increased expression of nitric oxide synthase [21,42] and abnormalities in brainstem auditory evoked potentials (BAEPs) of rats [4]. In clinical cohorts, NTG administration triggers a mild immediate headache, which is stronger in migraine sufferers than in healthy subjects and derives from the acute vasodilatory effects of nitric oxide (NO) impacting the cerebral vasculature.…”